Ganglioneuroblastoma

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma [Phase 3]

  A Phase 3 trial is recruiting to test dinutuximab plus chemotherapy, surgery, and stem cell transplantation for newly diagnosed high-risk ne…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse [Phase 1, Phase 2]

  Clinical trial update describing the addition of iberdomide to therapy for neuroblastoma that has recurred or is refractory, in Phase 1/2 an…

• CLINICAL_TRIALS research · 2026-03-31
  Clinical Trial Update: An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors [EARLY_Phase 1]

  A Mayo Clinic-sponsored early-phase 1 trial is evaluating 68Ga-DOTATATE PET/CT as a diagnostic tool for pediatric metastatic neuroendocrine …

• CLINICAL_TRIALS trial_result · 2026-03-30
  Clinical Trial Update: Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma [Phase 1, Phase 2]

  This clinical trial update indicates a Phase 1/2 study of dual-target GD2/B7-H3 CAR-NK cells for pediatric relapsed or refractory neuroblast…

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma [Phase 2]

  This clinical trial update describes a Phase 2 study comparing 123I-MIBG and 18F-MFBG imaging in patients with newly diagnosed, high-risk ne…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) [Phase 3]

  This clinical trial update describes a Phase 3 study evaluating adding 131I-MIBG or lorlatinib to intensive therapy for high-risk neuroblast…

• CLINICAL_TRIALS research · 2026-01-29
  Clinical Trial Update: Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma [Phase 3]

  A Phase 3 clinical trial in pediatric patients with refractory or relapsed high-risk neuroblastoma and ganglioneuroblastoma is evaluating ch…

• CLINICAL_TRIALS research · 2025-12-30
  Clinical Trial Update: Phase II Study of Proton Radiation Therapy for Neuroblastoma [NA]

  A Phase II clinical trial is evaluating proton radiation therapy for neuroblastoma and related ganglioneuroblastoma, currently recruiting.

• CLINICAL_TRIALS research · 2025-12-22
  Clinical Trial Update: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma [Phase 3]

  A Phase 3 clinical trial update investigates response and biology-based risk-factor guided therapy for younger patients with non-high risk n…

• CLINICAL_TRIALS research · 2025-11-13
  Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

  This clinical trial update describes biomarker analysis in tumor tissue from patients with newly diagnosed neuroblastoma or ganglioneuroblas…

• CLINICAL_TRIALS research · 2025-07-22
  Clinical Trial Update: SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours [NA]

  The SIOPEN BIOPORTAL is an international registry connected to a virtual biobank for patients with peripheral neuroblastic tumors, with recr…

• CLINICAL_TRIALS research · 2025-05-28
  Clinical Trial Update: Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 [Phase 1]

  Phase 1 clinical trial evaluating ENCIT-01, an engineered neuroblastoma cellular immunotherapy, in patients with neuroblastoma or ganglioneu…

• CLINICAL_TRIALS trial_result · 2024-08-14
  Clinical Trial Update: Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) [Phase 2]

  A Phase 2 trial evaluating a multi-agent regimen of dinutuximab, GM-CSF, isotretinoin, irinotecan, and temozolomide after intensive therapy …

• CLINICAL_TRIALS research · 2024-05-20
  Clinical Trial Update: Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

  This clinical trial update reports ongoing recruitment for a study stratifying risk factors in abdominal neuroblastoma patients undergoing l…

• CLINICAL_TRIALS trial_result · 2023-10-10
  Clinical Trial Update: Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma [Phase 3]

  Phase 3 clinical trial evaluating induction chemoimmunotherapy in high-risk neuroblastoma; currently recruiting.

• CLINICAL_TRIALS trial_result · 2023-03-14
  Clinical Trial Update: Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 2]

  Phase 2 trial evaluating dinutuximab with sargramostim and combination chemotherapy for newly diagnosed high-risk neuroblastoma; results hav…

• CLINICAL_TRIALS trial_result · 2019-11-18
  Clinical Trial Update: Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma [Phase 2]

  A phase 2 trial evaluating irinotecan hydrochloride and temozolomide with temsirolimus or dinutuximab in younger patients with refractory or…

• CLINICAL_TRIALS trial_result · 2017-09-28
  Clinical Trial Update: Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin [Phase 1]

  Phase 1 trial assessing induction therapy with 131I-MIBG plus chemotherapy for newly diagnosed high-risk neuroblastoma patients undergoing s…

• CLINICAL_TRIALS trial_result · 2017-02-09
  Clinical Trial Update: Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 1]

  Phase 1 study assessing consolidation with busulfan and melphalan plus autologous stem cell transplant after chemotherapy in newly diagnosed…